Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 221Other hematologic neoplasm 198Myeloid 60Sarcoma 31Classical hematology 25Plasma cell 24Breast 23Genitourinary 17CNS 16Dermatologic 14Gynecologic 5Thoracic 4Other solid neoplasm 4Other neoplasm 4Head & Neck 4Gastrointestinal 4Tumor-Agnostic 2Other 1

Conditions

Osteosarcoma 1Mucositis 1

Interventions

Radiotherapy 5Surveys and Questionnaires 4Cisplatin 4angiotensin I (1-7) 3alvimopan 3Radiation 3Injections 3Water 2Vitamin D 2Tirzepatide 2RRx-001 2Mouthwashes 2Metformin 2Interleukin 1 Receptor Antagonist Protein 2High-Intensity Focused Ultrasound Ablation 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Calcium Dobesilate 2Amifostine 2Acetylcysteine 2tempol 1peppermint oil 1pegfilgrastim 1naloxegol 1methylnaltrexone 1methyl N-acetylsibirosaminide 1linaclotide 1licogliflozin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Methotrexate × Other × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡